THE EVEREST II HIGH SURGICAL RISK COHORT: EFFECTIVENESS OF TRANSCATHETER REDUCTION OF SIGNIFICANT MITRAL REGURGITATION IN HIGH SURGICAL RISK PATIENTS

The EVEREST II high surgical risk cohort included 351 high risk patients pooled from the EVEREST II High Risk Study and the EVEREST II REALISM Continued Access Study. As of July 2012, all patients completed 1 year follow–up and a subset of 211 patients completed 2 year follow–up. One year